All Companies
Ticker KNSA
SEC data is missing this company's latest quarter
You reached the page — here's exactly what KNSA is, and why it's out of scope for now.
What this ticker is
KNSA
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
United Kingdom
Mkt cap $6.3B
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares represents an equity interest in Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company focused on discovering, developing, and commercializing therapies for immune-mediated and inflammatory diseases. The company’s current portfolio centers on products and candidates such as…
Why we can't analyze it yet
SEC data is missing this company's latest quarter: the SEC's companyfacts (refetched) ends at 2026-03-31 while its index lists a statement period 2026-06-30 — the SEC's aggregation omitted the filing; not recoverable from any archive we read Found by the Foundation Sweep four-quarter pass 2026-09-11; held under the four-quarter coverage policy (2026-09-11) and released automatically once the pass resolves it.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
sec_omission